您的位置: 首页 > 农业专利 > 详情页

METHODS AND COMPOSITIONS FOR REDUCING IMMUNOGENICITY
专利权人:
CELGENE CORPORATION
发明人:
HARALAMBOS HADJIVASSILIOU,JEFFREY C. JOHNSON,JEONGHOON SUN,KANDASAMY HARIHARAN,LAWRENCE DEARTH
申请号:
BR112019020185
公开号:
BR112019020185A2
申请日:
2018.03.26
申请国别(地区):
BR
年份:
2020
代理人:
摘要:
methods and uses involving the combination of an anti-cd20 antibody, for example, rituximab with a therapeutic protein, for example, an antibody (for example, an antibody that specifically binds to human cd47) are provided in the present invention.são fornecidos na presente invenção métodos e usos envolvendo a combinação de um anticorpo anti-cd20, por exemplo, rituximab com uma proteína terapêutica, por exemplo, um anticorpo (por exemplo, um anticorpo que se liga especificamente à cd47 humana).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充